Publication | Closed Access
Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers
309
Citations
17
References
2020
Year
Remimazolam was characterized by a pharmacokinetic-pharmacodynamic profile with fast onset, fast recovery, and moderate hemodynamic side effects.
| Year | Citations | |
|---|---|---|
Page 1
Page 1